Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Farmers 'unsure' of antibiotics best practice
cow
Traditionally, drying-off practices among many dairy farmers have involved the blanket use of antibiotics.
Survey: 68 per cent unfamiliar with selective dry cow therapy

Dairy farmers may be unsure of best practice when it comes to antibiotics, a new survey suggests.

More than 200 farmers took part in a study by Farmers Weekly and animal health company Zoetis. Of these, only 68 per cent had heard of selective dry cow therapy.

From 1 October, all of Arla's producers will be required to use selective dry cow therapy, having discussed and agreed on the use of antibiotics with their vet. This is part of Arla's quality-assurance programme.

Traditionally, drying-off practices among many dairy farmers have involved the blanket use of antibiotics across all cows, to prevent and treat any new infections that develop during the dry period.

Now, amid concerns over antibiotic resistance, farmers are being urged to target their use of antibiotics.

Research also shows the use of narrow-spectrum antibiotics in low cell count cows could increase the risk of mastitis in the following lactation.

Of those farmers who had heard of selective dry cow therapy, 30 per cent were positive about it, saying they were practising it, thought it was progressive, or would make things better and cheaper.

Meanwhile, 32 per cent had concerns it would take more time, was risky, or could lead to an increase in cell counts.

Other key findings
  • 78 per cent are using an internal teal sealant.
  • 33 per cent said maintaining cleanliness at drying off is the biggest challenge.
  • 39 per cent said they choose different antibiotics for different cases in consultation with their vets.
  • 82 per cent said they are trying to adopt better hygiene to reduce antibiotics usage.


Mastitis expert Andrew Bradley, however, said he believes there may be some confusion over mastitis testing. Nearly a quarter (73 per cent) of farmers said they identify mastitis bacteria causing infection.

“I suspect that of the 73 per cent who claim to be testing for mastitis bacteria, many will be basing their results on bulk tank culture, which is not identifying mastitis bacteria," said Mr Bradley, who is director of Quality Milk Management Services.
“There is a huge misconception that if you do a bulk milk tank PCR it can tell you what mastitis-causing bacteria are present – this is complete nonsense. The vast amount of bacteria in a bulk tank is from the environment."

For the full results, visit: http://www.fwi.co.uk/livestock/exclusive-survey-results-use-of-antibiotics-on-UK-dairy-farms.htm

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.